Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women

Table 2 Multivariate regression analysis of predictors of transitioning between malaria treatments received before and during pregnancy

Variables	Log odds	Std. error	*OR (C.I.)**	1/OR ^†	p-value
Transition scenario ACT/QNN before and during pregnancy (1 → 1)
Constant	−1.298	1.461	0.273		0.374
Age	−0.032	0.043	0.969 (0.89–1.05)	1.03	0.456
Education level	0.049	0.119	1.05 (0.83–1.34)		0.678
Parity	−0.107	0.135	0.899 (0.69–1.68)	1.11	0.423
No. of ANC visits	0.011	0.098	1.011 (0.83–1.23)		0.913
Private clinic	2.286	1.085	9.84 (1.69–18.6)		0.035
Pharmacy	2.429	1.178	11.35 (1.53–23.8)		0.039
Public Health center	1.195	1.170	3.3 (0.44–6.8)		0.307
Hospital	2.009	1.098	7.46 (1.24–14.3)		0.067
Transition scenario ACT/QNN to SP before and during pregnancy (1 → 2)
Constant	0.267	1.267	1.31 (0.11–18.13)		0.833
Age	0.021	0.043	1.02 (0.94–1.11)		0.626
Education level	−0.038	0.119	1.04 (0.76–1.22)		0.754
Parity	0.169	0.134	1.18 (0.91–1.55)		0.208
No. of ANC visits	0.089	0.098	1.09 (0.90–1.33)		0.359
Private clinic	−1.776	0.834	0.169 (0.02–0.75)	5.9	0.033
Pharmacy	−1.684	0.954	0.186 (0.02–1.08)	5.4	0.078
Public Health center	−1.504	0.915	0.222 (0.03–1.19)	4.5	0.10
Hospital	−1.506	0.850	0.221 (0.03–1.02)	4.4	0.076

*OR: odds ratio, ^†inverse operation applied to OR estimates less than 1 only.
boldface figures indicate statistical significance at p less than 0.05 at the 95% confidence level.

ISSN: 1475-2875